Evidence map›Paper›PMID 23869017›Full record

ArticleScience (New York, N.Y.)2013

Developmental control of the melanocortin-4 receptor by MRAP2 proteins in zebrafish.

Julien A Sebag, Chao Zhang, Patricia M Hinkle, Amanda M Bradshaw, Roger D Cone

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Association of Mutations in theInternational journal of molecular sciences · 2026
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Julien A SebagDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Chao Zhang
Patricia M Hinkle
Amanda M Bradshaw
Roger D Cone
Vanderbilt University · USUniversity of Rochester Medical Center · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Melanocortin Signaling in Feeding BehaviorR01DK070332 · NIDDK · VANDERBILT UNIVERSITY · PI CONE, ROGER D. · 2004 to 2017
$6.1M
MODULATION OF RECEPTOR NUMBER IN CULTURED CELLSR01DK019974 · NIDDK · UNIVERSITY OF ROCHESTER · PI HINKLE, PATRICIA M. · 1986 to 2011
$4.1M
Study of Energy Homeostasis in a Genetic Model SystemR01DK075721 · NIDDK · VANDERBILT UNIVERSITY · PI CONE, ROGER D. · 2007 to 2010
$1.1M
Study of Energy Homeostasis in a Genetic Model SystemR56DK075721 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI CONE, ROGER D · 2006 to 2006
$154k
Development of allosteric modulators of the MC4 receptorF32DK091055 · NIDDK · VANDERBILT UNIVERSITY · PI SEBAG, JULIEN ALBERT · 2011 to 2011
$51k
NIDDK NIH HHS DK020593NIDDK NIH HHS DK070332NIDDK NIH HHS DK075721NIDDK NIH HHS DK19974NIDDK NIH HHS F23DK091055NIDDK NIH HHS F32 DK091055NIDDK NIH HHS P30 DK020593NIDDK NIH HHS R01 DK019974NIDDK NIH HHS R01 DK070332NIDDK NIH HHS R01 DK075721NIDDK NIH HHS R56 DK075721NIDDK NIH HHS T32 DK007563
6 · The paper itself

Abstract

The melanocortin-4 receptor (MC4R) is essential for control of energy homeostasis in vertebrates. MC4R interacts with melanocortin receptor accessory protein 2 (MRAP2) in vitro, but its functions in vivo are unknown. We found that MRAP2a, a larval form, stimulates growth of zebrafish by specifically blocking the action of MC4R. In cell culture, this protein binds MC4R and reduces the ability of the receptor to bind its ligand, α-melanocyte-stimulating hormone (α-MSH). A paralog, MRAP2b, expressed later in development, also binds MC4R but increases ligand sensitivity. Thus, MRAP2 proteins allow for developmental control of MC4R activity, with MRAP2a blocking its function and stimulating growth during larval development, whereas MRAP2b enhances responsiveness to α-MSH once the zebrafish begins feeding, thus increasing the capacity for regulated feeding and growth.

Indexed as

alpha-MSHAnimalsEmbryo, NonmammalianEnergy MetabolismHEK293 CellsHumansReceptor Activity-Modifying ProteinsReceptor, Melanocortin, Type 4ZebrafishZebrafish Proteinsalpha-MSHReceptor Activity-Modifying ProteinsReceptor, Melanocortin, Type 4Zebrafish Proteins

Identifiers

PMID23869017
PMCPMC4255277
OpenAlexW2036800202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.